This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Contract research, development and manufacturing organisation (CRDMO) WuXi STA has broken ground on its new 190-acre pharmaceuticalmanufacturing campus in Middletown, Delaware, US. The biopharmaceutical industry is part of Delaware’s DNA,” stated Delaware Governor John Carney.
Consequently, pharmaceuticalmanufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Essentially, both counterfeit and falsified medicines pose risks to public health and threaten to undermine the healthcare system and pharmaceutical industry. About the author.
The growing demand from customers and pressures from global competitors have increased the significance of active pharmaceutical ingredients (API) chemical companies in the pharmaceutical industry supply chain.
Pharmaceuticalmanufacturers know how important adherence to a treatment plan is and to help patients afford medications, manufacturer assistance programs are designed to make treatments more affordable. When treatments are missed or reduced, health outcomes suffer.
The pharmaceutical industry requires specialised and cost-effective commercial packaging solutions to improve efficiency and preserve the integrity of products through the entire supply chain, from primary packaging and labelling to shipping, delivery, storage and distribution to end users.
While India and Italy are known for their active pharmaceutical ingredient (API) industries and production of generic drugs, other countries such as Brazil, Canada, South Korea, and others also have provisions for the manufacture and sale of generic drugs before the patent expires. of gross domestic product (GDP).
Shanghai Fosun Pharmaceutical (Group) is to collaborate with the International Finance Corporation (IFC) to construct a new pharmaceutical production facility and distribution hub near Abidjan, Côte d’Ivoire. The IFC will provide two loans totalling $53.49m (€50m) to Fosun Pharma’s subsidiaries.
Amidst numerous warning letters distributed by the US Food and Drug Administration (FDA) to pharmaceuticalmanufacturers in recent months, in July this year, the US regulatory body published its analysis on drug product quality in 2022. In subsequent years, up to 2022, half this number or less were issued. Edge Biologicals Inc.,
The pandemic effectively shut down supply chain paths overnight, and as a result, pharmaceuticalmanufacturers have faced delays and bottlenecks, which have caused drug shortages in healthcare systems. Until the company is found to be in compliance, there will not be a normal distribution of drug products.
Sanofi has signed definitive agreements with Adragos Pharmaceutical, a German contract development and manufacturing organisation (CDMO), for the sale of its pharmaceuticalmanufacturing site in Kawagoe, Japan. The French pharmaceutical company will also enter into a long-term supply agreement with the CDMO.
The US Food and Drug Administration (FDA) believes the adulteration of heparin was an economically motivated act—a clear breach of the US pharmaceutical supply chain. Supply chain issues in healthcare are damn scary. In other words, money over safety. The post Should we be worried about pharma’s supply chain?
International companies investing in the emerging market of Brazilian pharmaceuticalmanufacturing will see a higher return on investment than from developed market equivalents, if they choose to compete with local manufacturers to supply Brazil’s growing market and the greater South American region.
In announcing the results of price negotiations between the Centers for Medicare & Medicaid Services (CMS) and pharmaceuticalmanufacturers, the federal government has demonstrated that it can replicate private payers’ ability to reduce the net price of treatment while focusing on the clinical benefit of a treatment versus therapeutic alternatives (..)
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content